138 related articles for article (PubMed ID: 23816270)
1. Evaluating national practice of preoperative radiotherapy for rectal cancer based on clinical auditing.
van Leersum NJ; Snijders HS; Wouters MW; Henneman D; Marijnen CA; Rutten HR; Tollenaar RA; Tanis PJ;
Eur J Surg Oncol; 2013 Sep; 39(9):1000-6. PubMed ID: 23816270
[TBL] [Abstract][Full Text] [Related]
2. Changes in nationwide use of preoperative radiotherapy for rectal cancer after revision of the national colorectal cancer guideline.
Gietelink L; Wouters MWJM; Marijnen CAM; van Groningen J; van Leersum N; Beets-Tan RGH; Tollenaar RAEM; Tanis PJ;
Eur J Surg Oncol; 2017 Jul; 43(7):1297-1303. PubMed ID: 28351504
[TBL] [Abstract][Full Text] [Related]
3. Variability in the quality of rectal cancer care in public hospitals in Catalonia (Spain): clinical audit as a basis for action.
Manchon-Walsh P; Borras JM; Espinas JA; Aliste L;
Eur J Surg Oncol; 2011 Apr; 37(4):325-33. PubMed ID: 21296543
[TBL] [Abstract][Full Text] [Related]
4. Age-related guideline adherence and outcome in low rectal cancer.
Schiphorst AH; Verweij NM; Pronk A; Hamaker ME
Dis Colon Rectum; 2014 Aug; 57(8):967-75. PubMed ID: 25003291
[TBL] [Abstract][Full Text] [Related]
5. Preoperative treatment selection in rectal cancer: a population-based cohort study.
Elliot AH; Martling A; Glimelius B; Nordenvall C; Johansson H; Nilsson PJ
Eur J Surg Oncol; 2014 Dec; 40(12):1782-8. PubMed ID: 25260598
[TBL] [Abstract][Full Text] [Related]
6. The influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands, 1995 to 2002.
Vulto AJ; Lemmens VE; Louwman MW; Janssen-Heijnen ML; Poortmans PH; Lybeert ML; Coebergh JW
Cancer; 2006 Jun; 106(12):2734-42. PubMed ID: 16703598
[TBL] [Abstract][Full Text] [Related]
7. Population-based study of trends and variations in radiotherapy as part of primary treatment of cancer in the southern Netherlands between 1988 and 2006, with an emphasis on breast and rectal cancer.
Vulto JC; Lybeert ML; Louwman MW; Poortmans PM; Coebergh JW
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):464-71. PubMed ID: 19289268
[TBL] [Abstract][Full Text] [Related]
8. Improved guideline compliance after a 3-year audit of multidisciplinary colorectal cancer care in the western part of the Netherlands.
van der Geest LG; Krijnen P; Wouters MW; Erkelens WG; Marinelli AW; Nortier HJ; Tollenaar RA; Struikmans H;
J Surg Oncol; 2012 Jul; 106(1):1-9. PubMed ID: 22234959
[TBL] [Abstract][Full Text] [Related]
9. Adherence to treatment guidelines in stage II/III rectal cancer in Alberta, Canada.
Eldin NS; Yasui Y; Scarfe A; Winget M
Clin Oncol (R Coll Radiol); 2012 Feb; 24(1):e9-17. PubMed ID: 21802914
[TBL] [Abstract][Full Text] [Related]
10. Nationwide analysis of hospital variation in preoperative radiotherapy use for rectal cancer following guideline revision.
Detering R; de Neree Tot Babberich MPM; Bos ACRK; Dekker JWT; Wouters MWJM; Bemelman WA; Beets-Tan RGH; Marijnen CAM; Hompes R; Tanis PJ;
Eur J Surg Oncol; 2020 Mar; 46(3):486-494. PubMed ID: 31882252
[TBL] [Abstract][Full Text] [Related]
11. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
12. Assessing the effectiveness of a guideline recommendation for pre-operative radiochemotherapy in rectal cancer.
Manchon-Walsh P; Borras JM; Espinas JA; Aliste L;
Radiother Oncol; 2011 May; 99(2):142-7. PubMed ID: 21571385
[TBL] [Abstract][Full Text] [Related]
13. Current practice in preoperative therapy and surgical management of locally advanced rectal cancer: a bi-national survey.
Ooi K; Frizelle F; Ong E; Faragher I
Colorectal Dis; 2012 Jul; 14(7):814-20. PubMed ID: 21899709
[TBL] [Abstract][Full Text] [Related]
14. Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer.
Sloothaak DA; Geijsen DE; van Leersum NJ; Punt CJ; Buskens CJ; Bemelman WA; Tanis PJ;
Br J Surg; 2013 Jun; 100(7):933-9. PubMed ID: 23536485
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a Completion Total Mesorectal Excision in Patients After Local Excision of Rectal Cancer: A Word of Caution.
van Groningen JT; van Hagen P; Tollenaar RAEM; Tuynman JB; de Mheen PJM; Doornebosch PG; Tanis PJ; de Graaf EJR;
J Natl Compr Canc Netw; 2018 Jul; 16(7):822-828. PubMed ID: 30006424
[No Abstract] [Full Text] [Related]
16. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy comparison of neoadjuvant radiotherapy with or without chemotherapy for locally advanced rectal cancer].
Wu B; Qiu HZ; Xiao Y; Lin GL; Niu BZ; Zhang FQ; Hu K
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Mar; 11(2):124-7. PubMed ID: 18344077
[TBL] [Abstract][Full Text] [Related]
18. Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes?
Sun Myint A; Mukhopadhyay T; Ramani VS; Perkins K; Snee AJ; Jelley F; Wong H; Lee CD
Colorectal Dis; 2010 Aug; 12 Suppl 2():30-6. PubMed ID: 20618365
[TBL] [Abstract][Full Text] [Related]
19. Lymph node yield in rectal cancer surgery: effect of preoperative chemoradiotherapy.
Morcos B; Baker B; Al Masri M; Haddad H; Hashem S
Eur J Surg Oncol; 2010 Apr; 36(4):345-9. PubMed ID: 20071133
[TBL] [Abstract][Full Text] [Related]
20. Diminishing differences in treatment between patients with colorectal cancer with and without diabetes: a population-based study.
Zanders MM; van Steenbergen LN; Haak HR; Rutten HJ; Pruijt JF; Poortmans PM; Lemmens VE; van de Poll-Franse LV
Diabet Med; 2013 Oct; 30(10):1181-8. PubMed ID: 23758334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
